Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 9, 2008, Pages 2356-2365

  Bray, Freddie ^a,b   Haugen, Marion ^b   Moger, Tron A ^b   Tretli, Steinar ^a   Aalen, Odd O ^a,b   Grotmol, Tom ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; FEMALE; GENETIC SUSCEPTIBILITY; GEOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; REGISTRIES; WORLD HEALTH;

EID: 53349143374     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0461     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Vols. I to VIII. IARC Cancer Base No. 7. Lyon: IARC; 2005.
4. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al. Cancer Incidence in Five Continents. Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007.
5. Parkin DM, Whelan SL, Ferlay J, Bah E, Hamdi-Cherif M. Cancer in Africa. IARC Scientific Publications 153. Lyon: IARC; 2003.
6. Yu MC, Yuan J. Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni-JF J, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 620-6.
7. Klein G. Nasopharyngeal carcinoma (NPC) is an enigmatic tumor. Semin Cancer Biol 2002;12:415-8.
8. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-77.
9. Henle W, Henle G. The cause of infectious mononucleosis. A review. In: Briggs PM, De-Thé G, Payne LM, editors. Oncogenesis and herpes viruses. Lyon: IARC; 1972. p. 269-74.
10. Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res 1974;34:1189-91.
11. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993;15:466-85.
12. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours. pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.
13. Burt RD, Vaughan TL, McKnight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer 1992;52:549-56.
14. Balakrishnan U. An additional younger-age peak for cancer of the nasopharynx. Int J Cancer 1975;15:651-7.
15. Nwaorgu OG, Ogunbiyi JO. Nasopharyngeal cancer at the University College Hospital Ibadan Cancer Registry: an update. West Afr J Med 2004;23:135-8.
16. Barista I, Varan A, Ozyar E. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma. Med Hypotheses 2007;68:1421.
17. Andejani AA, Kundapur V, Malaker K. Age distribution of nasopharyngeal cancer in Saudi Arabia. Saudi Med J 2004;25:1579-82.
18. MacMahon B, Pugh H. Epidemiology: principles and methods. Philadelphia: Lippincott Willams and Wilkins; 1970.
19. Henderson BE. Nasopharyngeal carcinoma: present status of knowledge. Cancer Res 1974;34:1187-8.
20. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report. New York: Springer; 1966.
21. Segi M, Kurihara M. Cancer mortality for selected sites in 24 countries (1950-1957). 2nd ed. Sendai: Tohoku University of Medicine; 1960.
22. Rothwell RI. Juvenile nasopharyngeal carcinoma in Sabah (Malaysia). Clin Oncol 1979;5:353-8.
23. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002;94:1780-9.
24. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996;5:587-93.
25. Levine PH, Pocinki AG, Madigan P, Bale S. Familial nasopharyngeal carcinoma in patients who are not Chinese. Cancer 1992;70:1024-9.
26. Vaughan TL, Stewart PA, Teschke K, et al. Occupational exposure to formaldehyde and wood dust and nasopharyngeal carcinoma. Occup Environ Med 2000;57:376-84.
27. Zhu K, Levine RS, Brann EA, Gnepp DR, Baum MK. A population-based case-control study of the relationship between cigarette smoking and nasopharyngeal cancer (United States). Cancer Causes Control 1995;6:507-12.
28. Sun LM, Epplein M, Li CI, Vaughan TL, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. Am J Epidemiol 2005;162:1174-8.
29. Cogliano VJ, Grosse Y, Baan RA, Straif K, Secretan MB, El Ghissassi F. Meeting report: summary of IARC monographs on formaldehyde, 2-butoxyethanol, and 1-tert-butoxy-2-propanol. Environ Health Perspect 2005;113:1205-8.
30. Bosetti C, McLaughlin JK, Tarone RE, Pira E, La Vecchia C. Formaldehyde and cancer risk: a quantitative review of cohort studies through 2006. Ann Oncol 2008;19:29-43.
31. Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 2003;4:13-21.
32. Farrow DC, Vaughan TL, Berwick M, Lynch CF, Swanson GM, Lyon JL. Diet and nasopharyngeal cancer in a low-risk population. Int J Cancer 1998;78:675-9.
33. Tse LA, Yu IT, Mang OW, Wong SL. Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong. Br J Cancer 2006;95:1269-73.
34. Shanmugaratnam K, Lee HP, Day NE. Cancer incidence in Singapore, 1968-1977. Lyon: IARC Scientific Publications No. 47; 1983.
35. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer 2006;6:178.
36. Lee AW, Foo W, Mang O, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. Int J Cancer 2003;103:680-5.
37. Luo J, Chia KS, Chia SE, Reilly M, Tan CS, Ye W. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. Eur J Epidemiol 2007;22:513-21.
38. Hsu C, Shen YC, Cheng CC, Hong RL, Chang CJ, Cheng AL. Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 2006;15:856-61.
39. Yu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer 1989;43:1077-82.
40. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 1990;82:291-6.
41. Melbye M, Ebbesen P, Levine PH, Bennike T. Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma. Int J Cancer 1984;34:619-23.
42. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-68.
43. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:451-62.
44. Aalen OO, Tretli S. Analyzing incidence of testis cancer by means of a frailty model. Cancer Causes Control 1999;10:285-92.
45. Moger TA, Aalen OO, Halvorsen TO, Storm HH, Tretli S. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 2004;5:1-14.